• Mira Smart Conferencing
  • Home
  • Table of Contents
  • Advanced Search
 
Advanced Search

Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

  • UCSF, Multiple Sclerosis Center, San Francisco, CA

Filter

Partial Search: Partial searches may be entered manually by pressing enter in the filter input field.
Author Filter: Selecting one or more Authors from the Author drop down list will filter results by Author last name(s) only.

Displaying 1 - 5 of 6

  • Page:
  • 1
  • 2

Association of B cell Subsets and Aquaporin-4 antibody titers with Disease Activity in Participants in the N-MOmentum trial Receiving Inebilizumab Treatment

Author:Pittock, Sean   Paul, Friedemann   Kim, Ho Jin   Smith, Michael   Rees, William   Patterson, Kristina   Cree, Bruce   Bennett, Jeffrey   

Session Name:S5: Autoimmune Neurology: NMOSD and MG, A Focus on Treatment Trials  

Topic:Autoimmune Neurology  

Program Number:S5.005  

Author Institution:Mayo Clinic Dept of Neuro, Rochester, MN  Charite Universitatsmedizin in Berlin, Berlin, Germany  National Cancer Center, Goyang, Korea, Republic of  Horizon Therapeutics plc, Gaithersburg, MD  Horizon Therapeutics plc, Deerfield, IL  UCSF, Multiple Sclerosis Center, San Francisco, CA  University of Colorado School of Medicine, Aurora, CO  

  • View Abstract
  • View Disclosure

Association of Daily Physical Activity with Cervical Spinal Cord Areas in Multiple Sclerosis

Author:Block, Valerie   Cheng, Shuiting   Juwono, Jeremy   Cuneo, Richard   Kirkish, Gina   Alexander, Amber   Khan, Mahir   Akula, Amit   caverzasi, eduardo   Papinutto, Nico   Stern, William   MS-EPIC Team, University of California, San Francisco   Pletcher, Mark   Marcus, Gregory   Olgin, Jeffrey   Hauser, Stephen   Gelfand, Jeffrey   Bove, Riley   Cree, Bruce   Henry, Roland   

Session Name:S27: MS Neuroimaging  

Topic:MS and Inflammatory Disease  

Program Number:S27.009  

Author Institution:University of California, San Francisco, San Francisco, CA  UCSF, Multiple Sclerosis Center, San Francisco, CA  University of Pavia, Pavia, Italy  University of California San Francisco, San Francisco, CA  UCSF Weill Institute for Neurosciences, San Francisco, CA  

  • View Abstract
  • View Disclosure

Disease Outcomes With Ublituximab in Participants With Highly Active Disease: Subpopulation Analyses of the Phase 3 ULTIMATE I and II Studies in Participants With Relapsing Multiple Sclerosis

Author:Alvarez, Enrique   Steinman, Lawrence   Hartung, Hans-Peter   Fox, Edward   Qian, Peiqing   Wray, Sibyl   Robertson, Derrick   Mok, Koby   Garner, Christopher A   Cree, Bruce   

Session Name:P6: MS Clinical Trials  

Topic:MS and Inflammatory Disease  

Program Number:P6.002  

Author Institution:University of Colorado, Aurora, CO  Stanford Medicine, Stanford, CA  Heinrich Heine University Medical Faculty Departme, Dusseldorf, Germany  Central Texas Neurology Consultants, Round Rock, TX  Swedish Medical Center, Seattle, WA  Hope Neurology, Knoxville, TN  University of South Florida, Tampa, FL  TG Therapeutics, Seal Beach, CA  TG Therapeutics, New York, NY  UCSF, Multiple Sclerosis Center, San Francisco, CA  

  • View Abstract
  • View Disclosure

Ublituximab Efficacy in Treatment-Naive Participants With Relapsing Multiple Sclerosis in the Phase 3 ULTIMATE I and II Studies

Author:Steinman, Lawrence   Fox, Edward   Hartung, Hans-Peter   Alvarez, Enrique   Qian, Peiqing   Wray, Sibyl   Robertson, Derrick   Huang, Deren   Selmaj, Krzysztof   Wynn, Daniel   Bosco, Jenna   Mok, Koby   Garner, Christopher A   Cree, Bruce   

Session Name:P6: MS Clinical Trials  

Topic:MS and Inflammatory Disease  

Program Number:P6.015  

Author Institution:Stanford Medicine, Stanford, CA  Central Texas Neurology Consultants, Round Rock, TX  Heinrich Heine University Düsseldorf, Dusseldorf, Germany  University of Colorado, Aurora, CO  Swedish Medical Center, Seattle, WA  Hope Neurology, Knoxville, TN  University of South Florida, Tampa, FL  Mount Carmel Neurology, Powell, OH  University of Warmia and Mazury, Lodz, Poland  Consultants in Neurology, Ltd., Northbrook, IL  TG Therapeutics, New York, NY  TG Therapeutics, Seal Beach, CA  UCSF, Multiple Sclerosis Center, San Francisco, CA  

  • View Abstract
  • View Disclosure

Safety and Efficacy of Inebilizumab in AQP4+ NMOSD Participants with History of Immunosuppression Treatment Prior to N-MOmentum Study

Author:Paul, Friedemann   Marignier, Roman   Lindsey, John   Kim, Ho Jin   She, Dewei   Cimbora, Daniel   Patterson, Kristina   Cree, Bruce   

Session Name:P13: Autoimmune Neurology: NMOSD / MOGAD / Optic Neuritis  

Topic:Autoimmune Neurology  

Program Number:P13.003  

Author Institution:Charite Universitatsmedizin in Berlin, Berlin, Germany  Hospices Civils de Lyon, Lyon, France  University of Texas Health Science Center at Houston, Houston, TX  National Cancer Center, Goyang, Korea, Republic of  Horizon Therapeutics plc, Gaithersburg, MD  Horizon Therapeutics plc, Deerfield, IL  UCSF, Multiple Sclerosis Center, San Francisco, CA  

  • View Abstract
  • View Disclosure

Displaying 1 - 5 of 6

  • Page:
  • 1
  • 2

© 2015 Mira Smart Conference | http://www.mirasmart.com